Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsTransplantation ConditioningHematopoietic Stem CellsGraft vs Host DiseaseBlood BanksHematologic NeoplasmsHematopoietic Stem Cell MobilizationAntigens, CD34Bone Marrow TransplantationGraft SurvivalMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisTreatment OutcomeCombined Modality TherapyTissue DonorsTransplantation ChimeraBusulfanCell DifferentiationMyeloablative AgonistsMultiple MyelomaCyclophosphamideRecurrenceBlood Component RemovalHistocompatibility TestingKidney TransplantationAntineoplastic Combined Chemotherapy ProtocolsMice, SCIDRemission InductionImmunosuppressive AgentsHistocompatibilityWhole-Body IrradiationLiver TransplantationCells, CulturedRetrospective StudiesLeukemiaLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingDisease-Free SurvivalVidarabineMesenchymal Stem Cell TransplantationTime FactorsGraft vs Leukemia EffectInfectionSurvival RateHematopoiesisEtoposideSurvival AnalysisTransplantation, IsogeneicThiotepaCell TransplantationSalvage TherapyHematologic DiseasesLeukemia, Myeloid, AcuteEmbryonic Stem CellsPOEMS SyndromeAmyloidosisCytomegalovirus InfectionsHeart TransplantationBlood CellsHodgkin DiseaseGraft RejectionSpinal CordMyelodysplastic SyndromesHLA AntigensFollow-Up StudiesAdult Stem CellsCytarabineAnemia, AplasticTransplantation ImmunologyVincristineLung TransplantationImmunosuppressionCyclosporineFatal OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred NODPrecursor Cell Lymphoblastic Leukemia-LymphomaCarmustineLymphomaLymphocyte DepletionPlatelet CountIfosfamideOpportunistic InfectionsTransplantationProspective StudiesPluripotent Stem CellsAcute DiseaseBlood DonorsChimerismBlood Group Incompatibility